Thermosensitive acetylated carboxymethyl chitosan gel depot systems sustained release caffeic acid phenethyl ester for periodontitis treatment

Periodontitis is a chronic inflammatory disease of tooth support tissues leading to progressive destruction of periodontal soft tissues as well as alveolar bone, and can be treated with anti‐inflammatory and bone‐protective agents to prevent disease progression. Caffeic acid phenethyl ester (CAPE) i...

Full description

Saved in:
Bibliographic Details
Published inPolymers for advanced technologies Vol. 34; no. 1; pp. 155 - 165
Main Authors Peng, Chengjun, Wang, Guichun, Wang, Yuxiao, Tang, Maomao, Ma, Xiaodong, Chang, Xiangwei, Guo, Jian, Gui, Shuangying
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.01.2023
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Periodontitis is a chronic inflammatory disease of tooth support tissues leading to progressive destruction of periodontal soft tissues as well as alveolar bone, and can be treated with anti‐inflammatory and bone‐protective agents to prevent disease progression. Caffeic acid phenethyl ester (CAPE) is a natural polyphenolic compound with anti‐inflammation, anti‐oxidation and bone tissue repair efficacy. In this work, we synthesized a thermosensitive hydrogel matrix of acetylated carboxymethyl chitosan (A‐CC), and firstly applied for periodontal local drug delivery. The biocompatible CAPE‐loaded A‐CC hydrogel (CAPE‐A‐CC) has the advantages of forming a drug depot in situ, sustained release and precisely improving the drug concentration in the lesion sites compared with traditional systemic administration. In addition, CAPE‐A‐CC could significantly inhibit the expression of inflammatory cytokines of TNF‐α, IL‐1β, IL‐6, and IL‐17 in macrophages, and increased the expression of alkaline phosphatase (ALP) in human periodontal ligament stem cells (hPDLSC) related to osteogenesis. This study develops a novel in situ thermosensitive hydrogel delivery system to improve the therapeutic potential of natural active ingredient for periodontitis therapy.
Bibliography:Funding information
Chengjun Peng and Guichun Wang contributed equally to this work.
National Natural Science Foundation of China, Grant/Award Number: 81873019; Postgraduate Education Foundation of College of Pharmacy of Anhui University of Chinese Medicine, Grant/Award Number: 21pyjj05; Academic and Technical Leaders in Anhui Province, Grant/Award Number: 2020D245; Key Project of Natural Science Research in Universities of Anhui Province, Grant/Award Numbers: KJ2021A0538, KJ2020A0429
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:1042-7147
1099-1581
DOI:10.1002/pat.5874